Experience with Thymoglobulin® induction therapy in pancreas transplant recipients.

被引:0
|
作者
Wiland, AM
Fink, JC
Philosophe, B
Farney, AC
Schweitzer, EJ
Colonna, JO
Weir, MR
Bartlett, ST
机构
[1] Univ Maryland, Sch Med, Dept Pharm Serv, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
1136
引用
收藏
页码:S408 / S408
页数:1
相关论文
共 50 条
  • [41] Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients.
    Parsons, R.
    Wolosyn, J.
    Lynch, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [42] Short course induction immunosuppression with thymoglobulin for renal transplant recipients
    Agha, IA
    Rueda, J
    Alvarez, A
    Singer, GG
    Miller, BW
    Flavin, K
    Lowell, JA
    Shenoy, S
    Howard, TK
    Ramachandran, V
    Irish, W
    Schnitzle, MA
    Brennan, DC
    TRANSPLANTATION, 2002, 73 (03) : 473 - 475
  • [43] Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience
    Vaitla, P.
    Patel, U.
    Cruz, A.
    Guisti, S.
    Moiz, A.
    Catherine, C. -S.
    Cohen, A.
    Loss, G.
    Bohorquez, H.
    Carmody, I.
    Reichman, T.
    Bruce, D.
    Anders, S.
    Garces, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [44] Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation
    Wiland, AM
    Fink, JC
    Philosophe, B
    Farney, AC
    Schweitzer, EJ
    Colonna, JO
    Weir, MR
    Bartlett, ST
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1910 - 1910
  • [45] Simultaneous Pancreas and Kidney Transplant Outcomes after Induction Therapy with Thymoglobulin Compared with Alemtuzumab.
    Masters, B.
    Bartlett, F.
    Drachenberg, C.
    Bartlett, S.
    Barth, R.
    Scalea, J.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 488 - 489
  • [46] Extended Duration of Rabbit Antithymocyte Globulin (rATG) Induction in Kidney and Kidney/Pancreas Transplant Recipients.
    Majmundar, D.
    Di Carlo, A.
    Diamond, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 944 - 945
  • [47] Outcomes in Standard vs. Extended Use of Thymoglobulin as Induction Therapy in Kidney Transplant Recipients
    Sifontis, N. M.
    Coleman, A.
    Tang, D.
    Lau, K.
    Karhadkar, S.
    DiCarlo, A.
    Diamond, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 688 - 689
  • [48] Induction therapy using rabbit anti-thymoglobulin and IVIG for hyperimmunized liver transplant recipients
    El Domiaty, N.
    Coilly, A.
    De Martin, E.
    Sacleux, S. -C.
    Ibrahim, W.
    Ichai, P.
    Azoulay, D.
    Vibert, E.
    Adam, R.
    Taupin, J. L.
    Cherqui, D.
    Samuel, D.
    Saliba, F.
    LIVER TRANSPLANTATION, 2024, 30 : 265 - 265
  • [49] Induction therapy using rabbit anti-thymoglobulin and IVIG for hyperimmunized liver transplant recipients
    El-Domiaty, Nada
    Coilly, Audrey
    De Martin, Eleonora
    Ibrahim, Wafaa
    Ichai, Philippe
    Azoulay, Daniel
    Vibert, Eric
    Adam, Rene
    Taupin, Jean Luc
    Cherqui, Daniel
    Samuel, Didier
    Saliba, Faouzi
    JOURNAL OF HEPATOLOGY, 2024, 80 : S378 - S378
  • [50] Thymoglobulin Induction Decreases Risk of Death in HLA-Sensitized Kidney Recipients.
    Loheac, C.
    Aubert, O.
    Assayag, M.
    Viglietti, D.
    Lefaucheur, C.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 330 - 330